Related Experiment Video
Updated: Jun 28, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Left Atrial Appendage Pseudothrombus Is Associated With Stroke History in Patients With Atrial Fibrillation
Edward Nicol1,2,3, Nabeela Karim4, Tom Semple2
1Cardiology Department Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust London UK.
Insights
Left atrial appendage pseudothrombus (LAAPT) is common in nonvalvular atrial fibrillation (NVAF) and significantly increases stroke risk. This finding on cardiovascular computed tomography (CCT) may help stratify stroke risk beyond the CHA2DS2-VASc score.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- The left atrial appendage (LAA) is a primary source of thrombus in nonvalvular atrial fibrillation (NVAF).
- Left atrial appendage pseudothrombus (LAAPT) is a filling defect on initial cardiovascular computed tomography (CCT) scans, with its clinical significance in NVAF patients being unclear.
- This study investigates the relationship between LAAPT and stroke history in NVAF patients.
Purpose of the Study:
- To determine the association between LAAPT identified on CCT and the history of stroke in patients with NVAF.
- To explore whether LAAPT can serve as an independent risk factor for stroke in this population.
Main Methods:
- A cohort of 213 consecutive NVAF patients undergoing CCT were assessed for LAAPT.
- Analysis included correlation of LA and LAA dimensions and morphology with clinical demographics and stroke history.
- Multivariable analysis was performed to assess the independent association of LAAPT with stroke, adjusting for the CHA2DS2-VASc score.
Main Results:
- LAAPT was identified in 27.7% of the 213 NVAF patients.
- Specific LAA characteristics, including larger ostium area, increased volume, and lower tortuosity, were associated with LAAPT.
- LAAPT on CCT was independently associated with a history of stroke (OR, 3.20) and remained significant after adjusting for the CHA2DS2-VASc score.
Conclusions:
- LAAPT is a prevalent finding on CCT in NVAF patients.
- LAAPT demonstrates a strong positive association with stroke prevalence, independent of the CHA2DS2-VASc score.
- LAAPT identified via CCT may offer additional value in stratifying stroke risk for NVAF patients.
Background:
In nonvalvular atrial fibrillation (NVAF), the left atrial appendage (LAA) is the source of thrombus in up to 90% of patients. LAA pseudothrombus (LAAPT), defined as a filling defect on the initial but not the 60-second delayed acquisition on cardiovascular computed tomography scan (CCT), is a recognized phenomenon in NVAF, with unknown clinical relevance. We aimed to determine the relationship between LAAPT and history of stroke in patients with NVAF.
Methods And Results:
The study included 213 consecutive patients with NVAF undergoing CCT who were assessed for LAAPT. LA and LAA dimensions and LAA morphology correlated with clinical demographics including cardiovascular risk factors, history of stroke, thromboembolic stroke, and transient ischemic attack. Mean age (±SD) was 65.1±10.5 years (range 31-89) and 150 of 213 (70.4%) were men. LAAPT was present in 59 of 213 (27.7%) patients. Greater mean LAA ostium area (5.7 versus 4.5, P<0.001), greater mean LAA ostium area:curved length (0.11 versus 0.08, P<0.001), increased LAA volume (14.0 versus 10.2, P<0.001), and lower mean LAA tortuosity index (1.17 versus 1.38, P<0.001) were all associated with the presence of LAAPT. On multivariable analysis, LAAPT on CCT (odds ratio [OR], 3.20 [95% CI, 1.40-7.20]; P<0.006) and higher CHA2DS2-VASc score (OR, 1.65 [95% CI, 1.16-2.35]; P=0.01) were associated with all strokes, with LAAPT remaining a statistically significant risk factor even after adjustment for CHA2DS2-VASc score.
Conclusions:
LAAPT on CCT is common in patients with NVAF. It has a strong positive association with stroke prevalence, even after adjustment for CHA2DS2-VASc score. LAAPT on CCT may potentially allow further stratification for stroke risk, additive to the CHA2DS2-VASc score.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Transient Ischemic Attack l: Introduction

